GSK Investigational Site

Burlington, Vermont 05405

0 studies enrolling now · 10 studies all time

What they study most

Chemotherapy-Induced Nausea and Vomiting, Epilepsy, Tonic-Clonic, Migraine, Migraine Disorders, Myasthaenia Gravis, Nausea, Nausea and Vomiting, Chemotherapy-Induced, Neoplasms, Breast, Restless Legs Syndrome, Restless Legs Syndrome (RLS), Sepsis, Systemic Lupus Erythematosus

Studies at this site

• A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE) — Completed
• A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting. — Completed
• GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults — Completed
• The Evaluation of Belimumab in Myasthenia Gravis (MG) — Completed
• Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures — Completed
• RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole — Completed
• Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer — Completed
• Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks — Completed
• Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy — Completed
• Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting — Completed